Emcure Pharmaceuticals' shares are trading at a premium of ₹270 in the unlisted market ahead of its IPO, which will open on July 3 and close on July 5. The company aims to raise ₹1,951.04 crore by selling shares in the range of ₹960 to ₹1,008 apiece. The IPO includes a fresh share sale of ₹800 crore and an offer-for-sale of 1.14 crore equity shares.
Read more at CNBCAd
Ad